Fundz

Oruka Therapeutics raised $200 million in a private placement to support its operations and growth.

PUBLIC · ORKASep 12, 2024

Amount Raised

$200 Million

Round Type

Post-IPO Equity

Menlo ParkBiotechnologyHealthcareHealth CareTherapeutics

Description

Oruka Therapeutics has successfully completed a private placement, securing $200 million in funding. This capital will be used to further the company's initiatives and support its ongoing development plans.

Quick answer

Oruka Therapeutics raised $200 Million in a Post-IPO Equity round, dated September 12, 2024. Oruka Therapeutics is based in Menlo Park, California, United States.

How much did Oruka Therapeutics raise?
Oruka Therapeutics raised $200 Million in a Post-IPO Equity round on September 12, 2024.
What does Oruka Therapeutics do?
Oruka Therapeutics is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases.
Where is Oruka Therapeutics based and how big is it?
Oruka Therapeutics is based in Menlo Park, California, United States.
Who are the decision-makers at Oruka Therapeutics?
Fundz holds 2 contacts at Oruka Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who to call at Oruka Therapeutics, and when

A new round usually means Oruka Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Oruka Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Oruka Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Oruka Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Oruka Therapeutics

Location

855 Oak Grove Ave.

Menlo Park, California, United States

About

Oruka Therapeutics is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Oruka's mission is to offer patients suffering from chronic skin diseases like plaque psoriasis the greatest possible freedom from their condition by achieving high rates of complete disease clearance with dosing as infrequently as one or twice a year. Oruka is advancing a proprietary portfolio of potentially best-in-class antibodies that were engineered by Paragon Therapeutics and target the core mechanisms underlying plaque psoriasis and other dermatologic and inflammatory diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Oruka Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Oruka Therapeutics's next move

See what Strategic adds

Oruka Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.